Cancer can be described as a condition associated with fibrosis, also called tumor fibrosis. This fibrotic reaction occurring in the tumor's microenvironment is referred to as desmoplasia. It is marked by an excessive turnover and transformation of the extracellular matrix (ECM). Within fibrous tumors, there is an augmented production and crosslinking of collagen, along with changes in collagen matrix degradation, leading to the disruption of tissue organization and cell behavior. This, in turn, results in the release of growth factors and the creation of hidden signaling-active sites on collagen.
Join us for a webinar on tumor fibrosis, where we will explore the latest advancements in cancer research with leading experts in the field. This webinar will provide a unique opportunity to hear from experts in the field and gain valuable insights into the latest advancements in tumor fibrosis research.
Join us to learn about cutting-edge approaches to developing new therapeutic targets, and the use of biomarkers for patient stratification and evaluating treatment efficacy.
The ECM Pharmacology Symposium Series is a close ongoing collaboration with The Extracellular Matrix Pharmacology Congress.
Please don't hesitate to contact us if you have any questions or other inquiries.